Rivbiosp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-12-29
Share capital
5 000,00 PLN
Activity description

Rivbio offers nucleic acid testing using Real Time PCR (qPCR) for qualitative and quantitative analyses. The company supplies kits for detecting pathogens and mutations in humans and animals, and provides nucleic acid extraction, genotyping and gene expression analysis.

Registered address
ul. Marsz. Józefa Piłsudskiego 74/320, 50-020 Wrocław, Poland
Website
rivbio.comWebsite active
Email
Email address current
Phone
Electronic delivery address
AE:PL-24374-67099-TVEHW-22

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 266.38kMedianUSD 38.54kAverageUSD 2.32m
Net profit
This companyUSD 57.64kMedianUSD -1.56kAverageUSD -88.44k
Operating costs
This companyUSD 205.81kMedianUSD 56.03kAverageUSD 2.29m
Assets
This companyUSD 98.71kMedianUSD 119.99kAverageUSD 2.73m

Bank accounts

Registered as a VAT taxpayer on 2023-01-05. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

7 public aid cases recorded, with a total value of $8,982.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$455
De minimis aid (in accordance with Commission Regulation 2023/2831)
$264
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,146

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Iwona Joanna Belusiak – President of the Management Board
Janusz Krzysztof Piechota – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Iwona Joanna Belusiak (37)
50$675.3150%
Janusz Krzysztof Piechota (49)
50$675.3150%

Beneficial owners

Person

Competitors

Name
Analytical R & Dsp. z o.o.
GenxoneS.A.
Polbiotech Laboratoriumsp. z o.o.
Vitrotest Europesp. z o.o.
GMT Foodsafetysp. z o.o.
Phage Consultantssp. z o.o.
Nexbiosp. z o.o.
IntelliseqS.A.
Relvosp. z o.o.
GMT GenomicsS.A.

FAQ

Last updated: 2026-04-30